Oct 31, 2019
Dr. Guy Chamberland, CEO, Tetra Bio-Pharma discusses why Tetra is focusing on developing cannabinoid-based therapies to help relieve chronic and breakthrough pain in patients with advanced cancers. He also speaks to how important it is to shorten the time to pain relief for those who are suffering. In the current climate of opioid abuse, Tetra is looking to help both doctors and patients with new options for their candidate therapies.
#cannabinoid #biopharma #advancedcancer #breakthroughpain